Atopic Dermatitis FDA Approves New Nonsteroidal Topical for AD: All About Tapinarof Cream, 1% (Vtama, Organon)
Atopic Dermatitis Tapinarof Cream 1% (Vtama, Organon) Approved in AD: Organon’s Phil Brown, MD, JD, Discusses the New Indication
Atopic Dermatitis U.S. FDA Approves Nemolizumab (Nemluvio, Galderma) for Patients with Moderate to Severe AD
